| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B CACNA1E CACNA1S SLC9A9 PKD1L3 CHRNA5 PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 SLC5A8 SLC9A6 | 1.77e-06 | 664 | 104 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | SLC43A2 CACNA1B CACNA1E CACNA1S SLC9A9 SLC7A7 PKD1L3 SLC7A14 CHRNA5 PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 LRP2 TMEM184C UQCRC1 SLC5A8 SVOP SLC9A6 | 2.54e-06 | 1289 | 104 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B CACNA1E CACNA1S SLC9A9 PKD1L3 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 SLC5A8 SLC9A6 | 5.49e-06 | 465 | 104 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC43A2 CACNA1B CACNA1E CACNA1S SLC9A9 SLC7A7 PKD1L3 SLC7A14 CHRNA5 PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 SLC5A8 SVOP SLC9A6 | 9.76e-06 | 1180 | 104 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 PIEZO2 SCN1A SCN2A KCNJ16 PKD1 | 1.23e-05 | 343 | 104 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B CACNA1E CACNA1S SLC9A9 PKD1L3 CHRNA5 PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 SLC5A8 SLC9A6 | 1.50e-05 | 793 | 104 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B CACNA1E CACNA1S SLC9A9 PKD1L3 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 SLC5A8 SLC9A6 | 2.27e-05 | 627 | 104 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.79e-05 | 14 | 104 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 PIEZO2 SCN1A SCN2A KCNJ16 PKD1 SLC5A8 | 9.34e-05 | 526 | 104 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 PIEZO2 SCN1A SCN2A KCNJ16 PKD1 | 1.42e-04 | 459 | 104 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B CACNA1E CACNA1S SLC9A9 PKD1L3 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 SLC5A8 SLC9A6 | 1.56e-04 | 758 | 104 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | gated channel activity | 3.61e-04 | 334 | 104 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.67e-04 | 27 | 104 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.83e-04 | 182 | 104 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.06e-04 | 184 | 104 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 PIEZO2 SCN1A SCN2A KCNJ16 PKD1 | 4.14e-04 | 525 | 104 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1B CACNA1E HSPG2 CDHR5 PKD1L3 DNAH7 SVEP1 UMODL1 TLL2 LRP2 EML1 ALOX15B | 5.21e-04 | 749 | 104 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | deubiquitinase activator activity | 5.55e-04 | 7 | 104 | 2 | GO:0035800 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 5.55e-04 | 31 | 104 | 3 | GO:0030247 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.74e-04 | 129 | 104 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate receptor activity | 7.37e-04 | 8 | 104 | 2 | GO:0038036 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 9.44e-04 | 9 | 104 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 9.44e-04 | 9 | 104 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.17e-03 | 151 | 104 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.46e-03 | 43 | 104 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 1.71e-03 | 12 | 104 | 2 | GO:0008239 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.77e-03 | 46 | 104 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.00e-03 | 102 | 104 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.02e-03 | 171 | 104 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 2.02e-03 | 13 | 104 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 2.35e-03 | 14 | 104 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.35e-03 | 14 | 104 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 3.07e-03 | 16 | 104 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.07e-03 | 16 | 104 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 3.07e-03 | 16 | 104 | 2 | GO:0045125 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.47e-03 | 17 | 104 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.34e-03 | 19 | 104 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.29e-03 | 21 | 104 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 5.68e-03 | 310 | 104 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 6.33e-03 | 23 | 104 | 2 | GO:0015464 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 CHRNA5 SELENOK PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 LRP2 UQCRC1 PRKG2 SLC5A8 SLC9A6 | 1.30e-05 | 1374 | 103 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 SELENOK PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 LRP2 UQCRC1 SLC5A8 SLC9A6 | 1.55e-05 | 1157 | 103 | 18 | GO:0006812 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.03e-05 | 230 | 103 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 SELENOK SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 LRP2 SLC5A8 SLC9A6 | 3.50e-05 | 1000 | 103 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 3.68e-05 | 75 | 103 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 UQCRC1 SLC9A6 | 6.67e-05 | 942 | 103 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 7.92e-05 | 142 | 103 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 7.92e-05 | 142 | 103 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | import into cell | SLC43A2 CACNA1B CACNA1E CACNA1S DPP4 HSPG2 SLC9A9 AHI1 HEATR5A XKR6 SLC11A1 KCNJ16 LRP2 ARHGAP27 SLC9A6 SORL1 | 8.18e-05 | 1074 | 103 | 16 | GO:0098657 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 CHRNA5 PIEZO2 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 UQCRC1 SLC9A6 | 1.26e-04 | 1115 | 103 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 UQCRC1 SLC5A8 SLC9A6 | 1.56e-04 | 1017 | 103 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B CACNA1E CACNA1S SLC9A9 SPHK2 PKD1L3 SLC11A1 SCN1A SCN2A KCNJ16 PKD1 TSPAN13 UQCRC1 SLC9A6 | 1.95e-04 | 922 | 103 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 2.45e-04 | 5 | 103 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | insulin receptor recycling | 2.45e-04 | 5 | 103 | 2 | GO:0038020 | |
| GeneOntologyCellularComponent | cation channel complex | 2.31e-05 | 235 | 104 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | endosome | CLEC18A SLC9A9 CLEC18B ARHGAP26 CLEC18C SCAMP2 WLS KIAA0319 TBC1D16 PTPN2 SPPL2A SLC11A1 RNFT1 LRP2 ARHGAP27 SLC9A6 SORL1 | 6.06e-05 | 1167 | 104 | 17 | GO:0005768 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 SCN1A SCN2A KCNJ16 PKD1 | 1.14e-04 | 378 | 104 | 9 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 | 2.81e-04 | 523 | 104 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1B CACNA1E CACNA1S PKD1L3 CHRNA5 SCN1A SCN2A KCNJ16 PKD1 UQCRC1 | 4.18e-04 | 550 | 104 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | calcium channel complex | 4.83e-04 | 73 | 104 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | endocytic vesicle | 6.70e-04 | 384 | 104 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | brush border | 9.82e-04 | 152 | 104 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.55e-03 | 46 | 104 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.96e-03 | 354 | 104 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | late endosome membrane | 2.02e-03 | 179 | 104 | 5 | GO:0031902 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.17e-03 | 462 | 104 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.17e-03 | 462 | 104 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | vesicle membrane | GIPC1 SLC9A9 ARHGAP26 SCAMP2 WLS KIAA0319 FAM170B MOXD1 SPPL2A SLC11A1 PKD1 LRP2 SVOP SLC9A6 SORL1 | 2.30e-03 | 1325 | 104 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.38e-03 | 112 | 104 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | basal part of cell | 2.83e-03 | 378 | 104 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GIPC1 CACNA1B CACNA1E CACNA1S ADCY4 WLS CHRM3 CHRNA5 SCN1A LRP2 RBM8A DMWD SLC9A6 SORL1 | 3.04e-03 | 1228 | 104 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | endosome membrane | SLC9A9 ARHGAP26 SCAMP2 WLS KIAA0319 SPPL2A SLC11A1 SLC9A6 SORL1 | 3.12e-03 | 602 | 104 | 9 | GO:0010008 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.18e-03 | 17 | 104 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | dendrite | GIPC1 CACNA1B CACNA1S ADCY4 WLS CHRM3 CHRNA5 LRP2 RBM8A DMWD SLC9A6 | 3.61e-03 | 858 | 104 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GIPC1 CACNA1B CACNA1S ADCY4 WLS CHRM3 CHRNA5 LRP2 RBM8A DMWD SLC9A6 | 3.67e-03 | 860 | 104 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | vacuolar membrane | 3.82e-03 | 507 | 104 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | early endosome membrane | 4.18e-03 | 212 | 104 | 5 | GO:0031901 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.18e-03 | 212 | 104 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | trans-Golgi network | 4.29e-03 | 306 | 104 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | node of Ranvier | 4.39e-03 | 20 | 104 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | presynapse | GIPC1 CACNA1B CACNA1E WDR7 CHRM3 CHRNA5 S1PR5 SCN1A SCN2A SVOP SLC9A6 | 4.59e-03 | 886 | 104 | 11 | GO:0098793 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | MARCHF6 SMPD4 OR2M3 WLS CHRM3 MOXD1 SELENOK SPPL2A OR11A1 ZDHHC9 RNFT1 HAS2 SLC9A6 SORL1 | 4.81e-03 | 1293 | 104 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | MARCHF6 SMPD4 OR2M3 WLS CHRM3 MOXD1 SELENOK SPPL2A OR11A1 ZDHHC9 RNFT1 HAS2 SLC9A6 SORL1 | 5.00e-03 | 1299 | 104 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.17e-03 | 223 | 104 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC9A9 ARHGAP26 SCAMP2 WLS KIAA0319 FAM170B MOXD1 SPPL2A SLC11A1 PKD1 LRP2 SVOP SLC9A6 SORL1 | 5.28e-03 | 1307 | 104 | 14 | GO:0030659 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.32e-03 | 320 | 104 | 6 | GO:0016323 | |
| MousePheno | impaired learning | 2.14e-05 | 146 | 81 | 7 | MP:0012315 | |
| Domain | VDCC_a1su_IQ | 5.45e-06 | 7 | 102 | 3 | IPR014873 | |
| Domain | GPHH | 5.45e-06 | 7 | 102 | 3 | PF16905 | |
| Domain | GPHH_dom | 5.45e-06 | 7 | 102 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 5.45e-06 | 7 | 102 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 5.45e-06 | 7 | 102 | 3 | PF08763 | |
| Domain | EGF_3 | 5.63e-06 | 235 | 102 | 9 | PS50026 | |
| Domain | EGF | 5.63e-06 | 235 | 102 | 9 | SM00181 | |
| Domain | LDLRA_1 | 6.25e-06 | 48 | 102 | 5 | PS01209 | |
| Domain | Lectin_C | 6.59e-06 | 84 | 102 | 6 | PF00059 | |
| Domain | LDLRA_2 | 6.93e-06 | 49 | 102 | 5 | PS50068 | |
| Domain | C-type_lectin-like | 7.55e-06 | 86 | 102 | 6 | IPR001304 | |
| Domain | EGF-like_dom | 8.97e-06 | 249 | 102 | 9 | IPR000742 | |
| Domain | WD40 | 1.23e-05 | 259 | 102 | 9 | PF00400 | |
| Domain | EGF-like_CS | 1.31e-05 | 261 | 102 | 9 | IPR013032 | |
| Domain | - | 1.42e-05 | 333 | 102 | 10 | 2.130.10.10 | |
| Domain | Channel_four-helix_dom | 1.47e-05 | 57 | 102 | 5 | IPR027359 | |
| Domain | - | 1.47e-05 | 57 | 102 | 5 | 1.20.120.350 | |
| Domain | EGF_2 | 1.48e-05 | 265 | 102 | 9 | PS01186 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.49e-05 | 335 | 102 | 10 | IPR015943 | |
| Domain | - | 1.51e-05 | 97 | 102 | 6 | 3.10.100.10 | |
| Domain | WD40 | 1.61e-05 | 268 | 102 | 9 | SM00320 | |
| Domain | C-type_lectin-like/link | 1.70e-05 | 99 | 102 | 6 | IPR016186 | |
| Domain | WD40_repeat | 1.81e-05 | 272 | 102 | 9 | IPR001680 | |
| Domain | VDCCAlpha1 | 1.85e-05 | 10 | 102 | 3 | IPR002077 | |
| Domain | WD_REPEATS_1 | 2.16e-05 | 278 | 102 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.22e-05 | 279 | 102 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.22e-05 | 279 | 102 | 9 | PS50294 | |
| Domain | CTDL_fold | 2.65e-05 | 107 | 102 | 6 | IPR016187 | |
| Domain | WD40_repeat_dom | 3.62e-05 | 297 | 102 | 9 | IPR017986 | |
| Domain | LDLR_class-A_CS | 6.59e-05 | 40 | 102 | 4 | IPR023415 | |
| Domain | - | 6.86e-05 | 15 | 102 | 3 | 3.40.33.10 | |
| Domain | CAP | 6.86e-05 | 15 | 102 | 3 | PF00188 | |
| Domain | CAP_domain | 6.86e-05 | 15 | 102 | 3 | IPR014044 | |
| Domain | SCP | 6.86e-05 | 15 | 102 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 6.86e-05 | 15 | 102 | 3 | IPR001283 | |
| Domain | EGF_1 | 7.85e-05 | 255 | 102 | 8 | PS00022 | |
| Domain | Na/H_exchanger_6 | 8.83e-05 | 3 | 102 | 2 | IPR002090 | |
| Domain | CLECT | 9.65e-05 | 84 | 102 | 5 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 1.02e-04 | 85 | 102 | 5 | PS50041 | |
| Domain | Ldl_recept_a | 1.05e-04 | 45 | 102 | 4 | PF00057 | |
| Domain | - | 1.15e-04 | 46 | 102 | 4 | 4.10.400.10 | |
| Domain | LH2 | 1.22e-04 | 18 | 102 | 3 | SM00308 | |
| Domain | LDrepeatLR_classA_rpt | 1.47e-04 | 49 | 102 | 4 | IPR002172 | |
| Domain | LDLa | 1.47e-04 | 49 | 102 | 4 | SM00192 | |
| Domain | PC1 | 1.76e-04 | 4 | 102 | 2 | IPR000434 | |
| Domain | PLAT | 1.96e-04 | 21 | 102 | 3 | PS50095 | |
| Domain | - | 1.96e-04 | 21 | 102 | 3 | 2.60.60.20 | |
| Domain | PLAT | 1.96e-04 | 21 | 102 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 1.96e-04 | 21 | 102 | 3 | IPR001024 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.00e-04 | 53 | 102 | 4 | IPR011047 | |
| Domain | SEA | 2.26e-04 | 22 | 102 | 3 | PF01390 | |
| Domain | SEA | 2.59e-04 | 23 | 102 | 3 | PS50024 | |
| Domain | SEA_dom | 2.59e-04 | 23 | 102 | 3 | IPR000082 | |
| Domain | Ion_trans_dom | 4.03e-04 | 114 | 102 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.03e-04 | 114 | 102 | 5 | PF00520 | |
| Domain | Na_trans_cytopl | 4.37e-04 | 6 | 102 | 2 | PF11933 | |
| Domain | PKD/REJ-like | 4.37e-04 | 6 | 102 | 2 | IPR002859 | |
| Domain | REJ | 4.37e-04 | 6 | 102 | 2 | PF02010 | |
| Domain | Na_trans_cytopl | 4.37e-04 | 6 | 102 | 2 | IPR024583 | |
| Domain | EGF_CA | 5.50e-04 | 122 | 102 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.93e-04 | 124 | 102 | 5 | IPR001881 | |
| Domain | Yip1 | 6.09e-04 | 7 | 102 | 2 | PF04893 | |
| Domain | Yip1 | 6.09e-04 | 7 | 102 | 2 | IPR006977 | |
| Domain | GPS | 8.37e-04 | 34 | 102 | 3 | SM00303 | |
| Domain | GPS | 9.12e-04 | 35 | 102 | 3 | PF01825 | |
| Domain | C_TYPE_LECTIN_1 | 9.65e-04 | 80 | 102 | 4 | PS00615 | |
| Domain | GPS | 9.91e-04 | 36 | 102 | 3 | PS50221 | |
| Domain | NaH_exchanger | 1.04e-03 | 9 | 102 | 2 | IPR004709 | |
| Domain | PKD/Chitinase_dom | 1.04e-03 | 9 | 102 | 2 | IPR022409 | |
| Domain | PKD | 1.04e-03 | 9 | 102 | 2 | SM00089 | |
| Domain | GPS | 1.07e-03 | 37 | 102 | 3 | IPR000203 | |
| Domain | EGF_CA | 1.26e-03 | 86 | 102 | 4 | PF07645 | |
| Domain | Na_channel_asu | 1.29e-03 | 10 | 102 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.29e-03 | 10 | 102 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.29e-03 | 10 | 102 | 2 | PF06512 | |
| Domain | PKD | 1.57e-03 | 11 | 102 | 2 | PS50093 | |
| Domain | PKD_dom | 1.57e-03 | 11 | 102 | 2 | IPR000601 | |
| Domain | PKD_channel | 1.57e-03 | 11 | 102 | 2 | PF08016 | |
| Domain | Cation/H_exchanger_CPA1 | 1.57e-03 | 11 | 102 | 2 | IPR018422 | |
| Domain | PKD1_2_channel | 1.57e-03 | 11 | 102 | 2 | IPR013122 | |
| Domain | - | 1.57e-03 | 11 | 102 | 2 | 2.60.40.670 | |
| Domain | C-type_lectin_CS | 1.67e-03 | 43 | 102 | 3 | IPR018378 | |
| Domain | EGF_Ca-bd_CS | 1.97e-03 | 97 | 102 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.12e-03 | 99 | 102 | 4 | PS01187 | |
| Domain | AA_permease_2 | 2.22e-03 | 13 | 102 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 2.22e-03 | 13 | 102 | 2 | IPR002293 | |
| Domain | Na_H_Exchanger | 2.57e-03 | 14 | 102 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 2.57e-03 | 14 | 102 | 2 | IPR006153 | |
| Domain | Ldl_recept_b | 2.57e-03 | 14 | 102 | 2 | PF00058 | |
| Domain | LDLRB | 2.57e-03 | 14 | 102 | 2 | PS51120 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.72e-03 | 106 | 102 | 4 | IPR000152 | |
| Domain | LY | 2.96e-03 | 15 | 102 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.96e-03 | 15 | 102 | 2 | IPR000033 | |
| Domain | PA | 4.75e-03 | 19 | 102 | 2 | PF02225 | |
| Domain | PA_domain | 4.75e-03 | 19 | 102 | 2 | IPR003137 | |
| Domain | EGF | 5.04e-03 | 126 | 102 | 4 | PF00008 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.41e-05 | 11 | 76 | 3 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.47e-04 | 23 | 76 | 3 | M47666 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.88e-04 | 108 | 76 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.01e-04 | 109 | 76 | 5 | MM15074 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 3.18e-04 | 25 | 76 | 3 | M47948 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.92e-04 | 178 | 76 | 6 | M2890 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 4.24e-04 | 6 | 76 | 2 | M47762 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 2.75e-08 | 3 | 106 | 3 | 26170455 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 2.75e-08 | 3 | 106 | 3 | 33603190 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 16709836 | ||
| Pubmed | SLC43A2 CLEC18A NAALAD2 WLS CHRM3 S1PR5 SPPL2A TSPAN13 ACSF3 RBM8A | 8.33e-07 | 430 | 106 | 10 | 16303743 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 9.55e-07 | 7 | 106 | 3 | 25818041 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SLC43A2 SLC9A9 MARCHF6 WLS CHRM3 S1PR5 SELENOK PKD1 UQCRC1 DMWD SVOP YIPF6 | 1.51e-06 | 697 | 106 | 12 | 28298427 |
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 28330839 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 16382099 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29649454 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38945311 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15610184 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 10827969 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19694741 | ||
| Pubmed | Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules. | 9.20e-06 | 2 | 106 | 2 | 27213360 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 9.20e-06 | 2 | 106 | 2 | 1317301 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33096315 | ||
| Pubmed | Tetraspanin-13 modulates voltage-gated CaV2.2 Ca2+ channels. | 9.20e-06 | 2 | 106 | 2 | 23648579 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31439038 | ||
| Pubmed | Genes for endosomal NHE6 and NHE9 are misregulated in autism brains. | 9.20e-06 | 2 | 106 | 2 | 23508127 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26311622 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 9.20e-06 | 2 | 106 | 2 | 15249644 | |
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 9.20e-06 | 2 | 106 | 2 | 12074836 | |
| Pubmed | Vestibular hair bundles control pH with (Na+, K+)/H+ exchangers NHE6 and NHE9. | 9.20e-06 | 2 | 106 | 2 | 17005858 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21377452 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30693367 | ||
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 20188150 | ||
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 24453333 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28784306 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32185219 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12610651 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32005694 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23859570 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18784617 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17544618 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18785627 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32845893 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28518218 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19270815 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 38996073 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18057008 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25155934 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11912251 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17928448 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 2.76e-05 | 3 | 106 | 2 | 24523520 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 14973256 | ||
| Pubmed | 3.52e-05 | 405 | 106 | 8 | 38187761 | ||
| Pubmed | 4.36e-05 | 126 | 106 | 5 | 17897319 | ||
| Pubmed | 4.91e-05 | 212 | 106 | 6 | 19521566 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 5.50e-05 | 4 | 106 | 2 | 32616470 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 17537961 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 35031483 | ||
| Pubmed | Activated cholinergic signaling provides a target in squamous cell lung carcinoma. | 5.50e-05 | 4 | 106 | 2 | 18559515 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 5.50e-05 | 4 | 106 | 2 | 26637798 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 16908842 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 29578003 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 21156207 | ||
| Pubmed | Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions. | 5.50e-05 | 4 | 106 | 2 | 21171650 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 5.50e-05 | 4 | 106 | 2 | 37141091 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 33844468 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 31253182 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 16482403 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 5.50e-05 | 4 | 106 | 2 | 8974318 | |
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 6.77e-05 | 71 | 106 | 4 | 8751373 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.95e-05 | 139 | 106 | 5 | 16985003 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 1679748 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 8825650 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 15522866 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 8812438 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 15451373 | ||
| Pubmed | Loss of galectin-3 impairs membrane polarisation of mouse enterocytes in vivo. | 9.15e-05 | 5 | 106 | 2 | 18211959 | |
| Pubmed | Voltage-Gated Ion Channels Are Transcriptional Targets of Sox10 during Oligodendrocyte Development. | 9.15e-05 | 5 | 106 | 2 | 38995010 | |
| Pubmed | T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. | 9.15e-05 | 5 | 106 | 2 | 19808259 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 11296258 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 19047013 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 24337656 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 1.37e-04 | 6 | 106 | 2 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.37e-04 | 6 | 106 | 2 | 12827191 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 24903384 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 9238069 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.37e-04 | 6 | 106 | 2 | 23652591 | |
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 12900400 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.91e-04 | 7 | 106 | 2 | 35176221 | |
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 20301424 | ||
| Pubmed | 1.98e-04 | 37 | 106 | 3 | 22432025 | ||
| Pubmed | 1.98e-04 | 37 | 106 | 3 | 29044125 | ||
| Pubmed | 2.32e-04 | 39 | 106 | 3 | 23864651 | ||
| Pubmed | 2.32e-04 | 39 | 106 | 3 | 20962850 | ||
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 33500317 | ||
| Pubmed | A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis. | 2.70e-04 | 41 | 106 | 3 | 23509962 | |
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 16382098 | ||
| Pubmed | Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46. | 3.27e-04 | 9 | 106 | 2 | 21183687 | |
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 11896452 | ||
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 15746173 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 3.62e-04 | 569 | 106 | 8 | 30639242 | |
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 16805797 | ||
| Pubmed | Common variants associated with general and MMR vaccine-related febrile seizures. | 4.08e-04 | 10 | 106 | 2 | 25344690 | |
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 16434032 | ||
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 20602612 | ||
| Cytoband | 2q24.3 | 6.55e-06 | 16 | 106 | 3 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.23e-04 | 127 | 106 | 4 | chr2q24 | |
| Cytoband | 8q24.12 | 4.05e-04 | 13 | 106 | 2 | 8q24.12 | |
| GeneFamily | WD repeat domain containing | 1.87e-06 | 262 | 78 | 9 | 362 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.87e-04 | 26 | 78 | 3 | 253 | |
| GeneFamily | Yip1 domain containing | 3.80e-04 | 7 | 78 | 2 | 105 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.49e-04 | 9 | 78 | 2 | 1203 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 7.32e-04 | 41 | 78 | 3 | 1298 | |
| GeneFamily | C-type lectin domain family | 1.09e-03 | 47 | 78 | 3 | 494 | |
| GeneFamily | Solute carriers | 1.57e-03 | 395 | 78 | 7 | 752 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.94e-06 | 56 | 101 | 5 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | DPP4 CLEC18A SLC9A9 ADCY4 AHI1 GGTA1 PIEZO2 SCN2A PRKG2 HAS2 | 3.96e-05 | 431 | 101 | 10 | gudmap_developingKidney_e13.5_podocyte cells_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 4.27e-05 | 41 | 101 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_500 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | DPP4 ADCY4 NAALAD2 YIPF4 WLS CLDN1 MLKL VPS13D PIEZO2 KCNJ16 RNFT1 TSPAN13 EML1 YIPF6 | 6.97e-05 | 878 | 101 | 14 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.00e-04 | 303 | 101 | 8 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k1 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.12e-04 | 20 | 101 | 3 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 1.16e-04 | 100 | 101 | 5 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_1000 | DPP4 CLEC18A YIPF4 CLDN1 MOXD1 PIEZO2 SCN2A KCNJ16 RNFT1 TSPAN13 LRP2 SLC5A8 HAS2 | 1.27e-04 | 814 | 101 | 13 | gudmap_kidney_e15.5_Podocyte_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | NAALAD2 AHI1 NR4A2 SLC7A7 CLDN1 NSD3 GGTA1 PTPN2 PIEZO2 SCN1A SCN2A YLPM1 HAS2 | 1.35e-04 | 819 | 101 | 13 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_200 | 1.53e-04 | 168 | 101 | 6 | gudmap_kidney_e15.5_Podocyte_MafB_200 | |
| CoexpressionAtlas | kidney | 1.56e-04 | 323 | 101 | 8 | kidney | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.92e-04 | 333 | 101 | 8 | gudmap_kidney_adult_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#2_top-relative-expression-ranked_200 | 1.97e-04 | 24 | 101 | 3 | gudmap_developingKidney_e11.5_ureteric bud_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.13e-04 | 430 | 101 | 9 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_1000 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.06e-04 | 191 | 101 | 6 | gudmap_kidney_adult_Podocyte_MafB_k1_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | DGCR2 DPP4 CDHR5 SLC7A7 CLDN1 NSD3 SUOX SCN2A KCNJ16 LRP2 PRKG2 SORL1 | 3.23e-04 | 778 | 101 | 12 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.77e-08 | 189 | 106 | 8 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.45e-07 | 179 | 106 | 7 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-07 | 193 | 106 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-07 | 193 | 106 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-07 | 193 | 106 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-07 | 195 | 106 | 7 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-07 | 198 | 106 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-07 | 198 | 106 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.43e-06 | 161 | 106 | 6 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 171 | 106 | 6 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 171 | 106 | 6 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-06 | 180 | 106 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-06 | 180 | 106 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 82d2daa39e3c31a74c08a5d77366740b87beb2fb | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 5.24e-06 | 184 | 106 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 186 | 106 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 6.49e-06 | 191 | 106 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 193 | 106 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 193 | 106 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-06 | 196 | 106 | 6 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.52e-06 | 196 | 106 | 6 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | distal-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.74e-06 | 197 | 106 | 6 | 6fcca7c071e35786b715adeb18be317d34315d7e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related-OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.20e-06 | 199 | 106 | 6 | c0dc14fb9899d4263264347436de121814441dfb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.20e-06 | 199 | 106 | 6 | 9bc53ff93ca97af4ee0f01c74a567987a26abb18 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | 8fd88dfc6e08e0186fc0f061526ad98a3b00bc31 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.70e-05 | 147 | 106 | 5 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 157 | 106 | 5 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 157 | 106 | 5 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.05e-05 | 160 | 106 | 5 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 160 | 106 | 5 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.05e-05 | 160 | 106 | 5 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-05 | 161 | 106 | 5 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-05 | 161 | 106 | 5 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-05 | 164 | 106 | 5 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 4.83e-05 | 166 | 106 | 5 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 4.83e-05 | 166 | 106 | 5 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-05 | 167 | 106 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 167 | 106 | 5 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 167 | 106 | 5 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-05 | 168 | 106 | 5 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.11e-05 | 168 | 106 | 5 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.41e-05 | 170 | 106 | 5 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 171 | 106 | 5 | 584a095ddcbf78aa29527f84b46b5ad3e2edbaa9 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 171 | 106 | 5 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 174 | 106 | 5 | 28ec25767bbd4fd898738f9f4d2b585dc91b5adf | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.04e-05 | 174 | 106 | 5 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 176 | 106 | 5 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 176 | 106 | 5 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-05 | 177 | 106 | 5 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 177 | 106 | 5 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | severe_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 6.55e-05 | 177 | 106 | 5 | 289f6aed6f054b04b01659434d8c8b467d1bf5dd | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 177 | 106 | 5 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.72e-05 | 178 | 106 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-05 | 180 | 106 | 5 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-05 | 180 | 106 | 5 | d8135f73a89b97168f2048258f4648e23536ece4 | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.09e-05 | 180 | 106 | 5 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.27e-05 | 181 | 106 | 5 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | 14faef1dde781d501834379f2a6413e8d6a80b72 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.47e-05 | 182 | 106 | 5 | 16186b7a0c33caa48631962381e3ab7e5d166163 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | edb0069c66b1465dcc0bb5881417c6b17184fd74 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.86e-05 | 184 | 106 | 5 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 7.86e-05 | 184 | 106 | 5 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 73ddf9d647d61381bab1e9c0d983736b6d390c15 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.06e-05 | 185 | 106 | 5 | 5fd4a3776259c96cf2dcb87f050af8226acbbda9 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.06e-05 | 185 | 106 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.06e-05 | 185 | 106 | 5 | 4c55fa96877ab9a00fcbec3fb70fd2208d222527 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-05 | 186 | 106 | 5 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 186 | 106 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 186 | 106 | 5 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.48e-05 | 187 | 106 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 8.70e-05 | 188 | 106 | 5 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 188 | 106 | 5 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 188 | 106 | 5 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 188 | 106 | 5 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.70e-05 | 188 | 106 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 188 | 106 | 5 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.70e-05 | 188 | 106 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-05 | 189 | 106 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-05 | 189 | 106 | 5 | 9e3c083174a64ea78648c6d48498fc4e721b569f | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.92e-05 | 189 | 106 | 5 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-05 | 189 | 106 | 5 | 6e19bfa52406ebe095daa99f958ec4d596ce6e39 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.14e-05 | 190 | 106 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.14e-05 | 190 | 106 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.14e-05 | 190 | 106 | 5 | 4498705c5c1c7ba88a26fd2f412cf1aadd0f572a | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.14e-05 | 190 | 106 | 5 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.14e-05 | 190 | 106 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 191 | 106 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.37e-05 | 191 | 106 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.37e-05 | 191 | 106 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.37e-05 | 191 | 106 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.37e-05 | 191 | 106 | 5 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.60e-05 | 192 | 106 | 5 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| Drug | lanthanum | 1.94e-07 | 136 | 103 | 8 | CID000023926 | |
| Drug | CNS 1145 | 3.69e-07 | 33 | 103 | 5 | CID000190902 | |
| Drug | IHC-64 | 3.69e-07 | 33 | 103 | 5 | CID000162753 | |
| Drug | AC1L2AC7 | 7.04e-07 | 69 | 103 | 6 | CID000068733 | |
| Drug | almagel | 8.93e-07 | 5 | 103 | 3 | CID003080942 | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.86e-06 | 194 | 103 | 8 | 5755_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A | 2.98e-06 | 195 | 103 | 8 | 2096_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.33e-06 | 198 | 103 | 8 | 3990_DN | |
| Drug | Cinildipine | 5.46e-06 | 56 | 103 | 5 | CID000002752 | |
| Drug | isradipine | 6.25e-06 | 100 | 103 | 6 | CID000003784 | |
| Drug | phenytoin | 7.00e-06 | 219 | 103 | 8 | CID000001775 | |
| Drug | nilvadipine | 7.70e-06 | 60 | 103 | 5 | CID000004494 | |
| Drug | IAA-94 | 8.36e-06 | 61 | 103 | 5 | CID000003667 | |
| Drug | lercanidipine | 9.81e-06 | 63 | 103 | 5 | CID000065866 | |
| Drug | lavendustin A | 1.29e-05 | 171 | 103 | 7 | CID000003894 | |
| Drug | gallopamil | 1.33e-05 | 67 | 103 | 5 | CID000001234 | |
| Drug | gastrodin | 1.44e-05 | 11 | 103 | 3 | CID000115067 | |
| Drug | lamotrigine | 1.47e-05 | 116 | 103 | 6 | CID000003878 | |
| Drug | NSC7524 | 1.93e-05 | 182 | 103 | 7 | CID000005657 | |
| Drug | CAS 298-57-7 | 2.02e-05 | 73 | 103 | 5 | CID000002761 | |
| Drug | aristolactam AII | 2.03e-05 | 2 | 103 | 2 | CID000148657 | |
| Drug | alkosin | 2.03e-05 | 2 | 103 | 2 | CID005488638 | |
| Drug | NSC229609 | 2.03e-05 | 2 | 103 | 2 | CID000069530 | |
| Drug | norcepharadione B | 2.03e-05 | 2 | 103 | 2 | CID000189168 | |
| Drug | piperolactam A | 2.03e-05 | 2 | 103 | 2 | CID003081016 | |
| Drug | ethosuximide | 2.16e-05 | 74 | 103 | 5 | CID000003291 | |
| Drug | sodium | SLC43A2 CACNA1S DPP4 SLC9A9 ADCY4 SLC7A7 SLC7A14 SLC11A1 SCN2A KCNJ16 PKD1 LRP2 PRKG2 SLC5A8 SLC9A6 | 2.22e-05 | 944 | 103 | 15 | CID000000923 |
| Drug | pimozide | 2.46e-05 | 127 | 103 | 6 | CID000016362 | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.63e-05 | 191 | 103 | 7 | 4094_DN | |
| Drug | nisoldipine | 2.79e-05 | 78 | 103 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.97e-05 | 79 | 103 | 5 | CID005287890 | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 2966_DN | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; HL60; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 1844_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 6557_UP | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 6274_UP | |
| Drug | 0393-0188; Down 200; 10uM; PC3; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 7536_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 3.21e-05 | 197 | 103 | 7 | 984_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 5865_DN | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 2455_DN | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 1797_UP | |
| Drug | nimodipine | 5.18e-05 | 145 | 103 | 6 | CID000004497 | |
| Drug | Dantrolene-13C3 | 5.18e-05 | 145 | 103 | 6 | CID000002951 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1B DGCR2 CACNA1E CACNA1S ADCY4 FPR3 MARCHF6 PKD1L3 BLK PKD1 PRKG2 | 5.31e-05 | 568 | 103 | 11 | CID000000806 |
| Drug | AC1NUZ8M | 6.18e-05 | 92 | 103 | 5 | CID000073211 | |
| Drug | Bay K 8644 | 6.25e-05 | 150 | 103 | 6 | CID000002303 | |
| Drug | manidipine | 7.21e-05 | 95 | 103 | 5 | CID000004008 | |
| Drug | isotetrandrine | 7.96e-05 | 97 | 103 | 5 | CID000005422 | |
| Drug | nitrendipine | 8.36e-05 | 98 | 103 | 5 | CID000004507 | |
| Drug | loperamide | 1.16e-04 | 105 | 103 | 5 | CID000003954 | |
| Drug | AC 110 | 1.21e-04 | 4 | 103 | 2 | CID000022860 | |
| Drug | riluzole | 1.42e-04 | 174 | 103 | 6 | CID000005070 | |
| Drug | papaverine | 1.51e-04 | 176 | 103 | 6 | CID000004680 | |
| Drug | potassium | CACNA1B CACNA1E CACNA1S SLC9A9 ADCY4 NR4A2 SLC7A7 PKD1L3 SLC11A1 SCN2A KCNJ16 PKD1 PRKG2 SLC9A6 | 1.78e-04 | 1008 | 103 | 14 | CID000000813 |
| Drug | AC1NBU2S | 1.93e-04 | 117 | 103 | 5 | CID004473765 | |
| Drug | mibefradil | 2.04e-04 | 64 | 103 | 4 | CID000060662 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.28e-04 | 190 | 103 | 6 | 2721_UP | |
| Drug | baclofen | 2.35e-04 | 191 | 103 | 6 | CID000002284 | |
| Drug | NSC759576 | 2.35e-04 | 191 | 103 | 6 | CID000003075 | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 2.48e-04 | 193 | 103 | 6 | 7371_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 4246_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 5695_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 3779_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 3298_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 3294_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 3268_UP | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 4549_UP | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 4593_UP | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 6483_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 5868_DN | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 4119_UP | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 5860_DN | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; HL60; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 6147_DN | |
| Drug | bepridil | 2.72e-04 | 126 | 103 | 5 | CID000002351 | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; HL60; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2934_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; HL60; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2433_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 1217_UP | |
| Drug | Betulin [473-98-3]; Up 200; 9uM; HL60; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2952_UP | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 6310_UP | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; HL60; HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2038_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2761_UP | |
| Drug | rapamycin; Down 200; 0.1uM; MCF7; HG-U133A | 2.77e-04 | 197 | 103 | 6 | 326_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 6306_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 3412_UP | |
| Drug | NU1025; Up 200; 100uM; MCF7; HG-U133A | 2.77e-04 | 197 | 103 | 6 | 313_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 5746_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 5735_DN | |
| Drug | NS-398; Up 200; 10uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 6892_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 5219_DN | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 5107_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 7221_UP | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 7509_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 3581_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 7331_UP | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 3749_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 2398_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 4252_DN | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; HL60; HG-U133A | 2.85e-04 | 198 | 103 | 6 | 2020_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 5048_UP | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 2064_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; PC3; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 4008_DN | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 3.68e-05 | 3 | 104 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 7.35e-05 | 4 | 104 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 2.55e-04 | 7 | 104 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.55e-04 | 7 | 104 | 2 | C0751057 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Febrile Convulsions | 4.36e-04 | 9 | 104 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.36e-04 | 9 | 104 | 2 | C3502809 | |
| Disease | heart rate response to exercise | 4.74e-04 | 43 | 104 | 3 | EFO_0009184 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.44e-04 | 10 | 104 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.44e-04 | 10 | 104 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 7.94e-04 | 12 | 104 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | DPP4 SLC9A9 YIPF4 XKR6 WLS DNAH7 SVEP1 TBC1D16 SUOX KCNJ16 PKD1 EML1 ARHGAP27 | 8.97e-04 | 1345 | 104 | 13 | EFO_0010736 |
| Disease | kynurenic acid measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0010506 | |
| Disease | Connective Tissue Diseases | 9.36e-04 | 13 | 104 | 2 | C0009782 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 9.36e-04 | 13 | 104 | 2 | C0751122 | |
| Disease | Intellectual Disability | 1.05e-03 | 447 | 104 | 7 | C3714756 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 1.09e-03 | 14 | 104 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | unipolar depression | CACNA1E TDRD9 NR4A2 CHRM3 DNAH7 BLK TBC1D16 PIEZO2 OR11A1 YLPM1 PKD1 EML1 | 1.11e-03 | 1206 | 104 | 12 | EFO_0003761 |
| Disease | MMR-related febrile seizures | 1.25e-03 | 15 | 104 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.43e-03 | 16 | 104 | 2 | C0393706 | |
| Disease | serum non-albumin protein measurement | 1.79e-03 | 361 | 104 | 6 | EFO_0004568 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.81e-03 | 18 | 104 | 2 | HP_0002373 | |
| Disease | X-11470 measurement | 2.02e-03 | 19 | 104 | 2 | EFO_0021241 | |
| Disease | Systemic Scleroderma | 2.02e-03 | 19 | 104 | 2 | C0036421 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.09e-03 | 152 | 104 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | monocyte count | DPP4 AHI1 TMEM121B SCAMP2 LCT SPPL2A L3MBTL1 YLPM1 KCNJ16 PKD1 VARS1 SORL1 | 2.37e-03 | 1320 | 104 | 12 | EFO_0005091 |
| Disease | eosinophilic esophagitis | 2.69e-03 | 163 | 104 | 4 | EFO_0004232 | |
| Disease | epilepsy (implicated_via_orthology) | 2.69e-03 | 163 | 104 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.71e-03 | 22 | 104 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | susceptibility to shingles measurement | 2.97e-03 | 81 | 104 | 3 | EFO_0008401 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGFTLEWGVYTIIED | 1091 | Q5DID0 | |
| EVGIHTKAWFIAGIF | 41 | Q9NVA4 | |
| GVTVGSIFEVVWAIF | 546 | Q15878 | |
| TFLFAGSEDGIVYVW | 856 | Q8N157 | |
| IADVWFIVGATVDTT | 636 | Q5T601 | |
| GGHTVWQVVFIAFLT | 61 | P20309 | |
| AFLFTGGVVSAWDQV | 106 | Q8NFM4 | |
| EFVFDVWGAIGDAKV | 316 | O14908 | |
| AFTLDGWFKTGDTVV | 446 | Q4G176 | |
| VWFGEDIGTEADVVV | 791 | Q9HBB8 | |
| FGVIVGSVFEVVWAA | 551 | Q00975 | |
| VVTGGEDDLVTVWSF | 341 | Q09019 | |
| ITVGSDGYVRIWDFE | 381 | Q96MT7 | |
| IVLATTEGEVFTWGH | 111 | O95199 | |
| VVSVVFIKELDGWVF | 131 | P98160 | |
| EGWILFVTGVHEEAT | 71 | Q9Y5S9 | |
| SVILVGAFVGWTLFF | 396 | P17706 | |
| GEEGSFIWVERVTLS | 336 | A6NDB9 | |
| LGTFWFTLREISFEG | 81 | Q8NGJ3 | |
| VVTTWLSGFVVDGLV | 146 | Q9GZK7 | |
| TLGVIFGVSWFLSQV | 201 | O95848 | |
| YDAGVSFIVVLVVWA | 201 | Q8N370 | |
| WIFSLLVHGVTFVFG | 26 | P25089 | |
| KAFGVTVDLWSIGVT | 196 | Q14164 | |
| STVAKWTIDEVFGFV | 746 | Q9Y468 | |
| WTIDEVFGFVQTLTG | 751 | Q9Y468 | |
| AFSWILGSTDGIIDV | 146 | Q8NG83 | |
| VGIWFTFSDLEEVIK | 166 | P09848 | |
| DGSLVFLEHVFWVVS | 281 | O60337 | |
| WGGVLITIVDTFFFL | 171 | P49279 | |
| FITKGTWEVIGIEAL | 396 | P27487 | |
| GVSLFEGQVFFTDWT | 606 | P98164 | |
| YSFGIVLWEIATGDI | 396 | Q8NB16 | |
| VGVWIDVGSRFETEK | 71 | P31930 | |
| VRGVAVAWETEAGFE | 116 | A6NMN3 | |
| GHDFSVDFWSLGILV | 626 | Q13237 | |
| VESIFGSLDGVLVGW | 91 | Q9NXE4 | |
| FLWTFLFVSIVGSLG | 431 | P30532 | |
| AYVVFVSTLGGAWLE | 306 | Q86XA9 | |
| FILAFLGWIGAIVST | 11 | O95832 | |
| GWNVLDFTIVFLGVF | 121 | Q13698 | |
| VFTIKADVWSFGVLL | 411 | P51451 | |
| FTIVGDAVGWGFVVR | 331 | Q8TB45 | |
| EGIFLFSLIWSVGAS | 1846 | Q8WXX0 | |
| VSVWFTILLGGVIFT | 481 | Q92819 | |
| GRWEVAFKGSSEVFL | 201 | P98153 | |
| VGTLTGRWFVFDTET | 601 | O00423 | |
| ALWFAREGGVFVALT | 106 | Q9H228 | |
| DTGVDVWAFGVLIFC | 231 | Q52WX2 | |
| LAVGWETGEVTVFNK | 76 | Q96RY7 | |
| VAVAVAVSGWVGASF | 3566 | P98161 | |
| WGAVERFVSEIIGIY | 481 | O15296 | |
| VRGFGEWIDSIVEFS | 476 | P43354 | |
| GTLLETGHDILFFWV | 816 | P26640 | |
| VITFDKGGTWEFLQA | 441 | Q92673 | |
| LLIEVFWAIGTVFEV | 211 | Q8N4V2 | |
| FWAIGTVFEVVLAVF | 216 | Q8N4V2 | |
| FLLAEAWGFTGVVAV | 341 | Q92581 | |
| TTLLIVFFTVWVFGG | 481 | Q92581 | |
| LLLVFFTVWVFGGGT | 466 | Q8IVB4 | |
| IATDLVVVVGWAIFF | 231 | Q9BXQ6 | |
| TIDVTEVVEVGHFWG | 901 | Q8NDG6 | |
| TVIIVFWEFINSTEG | 16 | Q4G0N0 | |
| SVAGFVWFSVAAVVL | 701 | Q9UNA1 | |
| SASWTVLEGGVLTFF | 521 | Q6ZUM4 | |
| VFERGGLDVFLLTTW | 786 | Q7Z443 | |
| GIGTFVVWDYVVFAG | 6 | Q8N695 | |
| GVDFGLSILWFLIFT | 181 | O15127 | |
| YIVTGGEDDLVTVWS | 276 | Q8TBZ3 | |
| LRDSGVEIFTFGIWQ | 211 | Q4LDE5 | |
| IGTVVFSWVGGFLSV | 141 | Q8NGC5 | |
| GWNIFDGFIVTLSLV | 831 | P35498 | |
| GLVSFVEVVSLWFAE | 116 | A5D8T8 | |
| GLASFVEVVSLWFAE | 116 | Q6UXF7 | |
| GLASFVEVVSLWFAE | 116 | Q8NCF0 | |
| VAVESEGSGIFSFVW | 81 | Q8N4M7 | |
| TVGEFVAFFIGWNLI | 126 | Q8TBB6 | |
| SLITDFFWGIAEFVV | 21 | Q9Y6D0 | |
| AFVVGAVVSGFSVGW | 606 | Q9H3T3 | |
| AVVSGFSVGWFVGLR | 611 | Q9H3T3 | |
| WIVLALLVFFGDVGT | 131 | Q5GH73 | |
| LLVFFGDVGTDLWLA | 136 | Q5GH73 | |
| EVFWIVGITDFILKF | 246 | Q5M7Z0 | |
| VTCWFGDGFAEVLRI | 406 | Q9BU70 | |
| LWSVVGLTGFHTFLV | 236 | Q9Y397 | |
| AEVFVIVWFGAVTIT | 121 | Q96EC8 | |
| LISGGFDRTVAIWDV | 336 | Q6ZMY6 | |
| GIGLFFSFTEILGVW | 171 | O95857 | |
| AGVIEAGLWVSLFHT | 336 | Q6UVY6 | |
| SFLSVAWGFVSDVDI | 331 | Q9NRA0 | |
| LSLVIWAVGGLFSVF | 71 | Q9UM01 | |
| FVIAVFTVALGGYWS | 176 | Q8TCT8 | |
| IFFGGIDVSIRGEVW | 421 | Q8TBP0 | |
| FGEWGSYVVDIFTTL | 51 | Q9NPI9 | |
| EGWNIFDGFIVSLSL | 821 | Q99250 | |
| ADTVDFIIIVFGFWA | 2196 | Q9H5I5 | |
| WVIVAEDGYGVELTF | 921 | Q9Y6L7 | |
| VLKIWDSVFFEGSEI | 446 | Q9Y2I9 | |
| EVSTGVKFQVGDLVW | 261 | Q9BZ95 | |
| IGFVVGQTDWEKITD | 2116 | P49750 | |
| FEVVSTLIKLFGVFW | 191 | Q9BSR8 | |
| WVTLGSEVFDVTEFV | 101 | P51687 | |
| TVIFFIVSQVTEGHW | 446 | Q5T9L3 | |
| YEITETGWGEFEIII | 86 | O95619 | |
| TGWGEFEIIIKIFFI | 91 | O95619 | |
| FFLISVFTILTGLGW | 121 | A6NGA9 | |
| ISGGVDFSVIIWDIF | 486 | Q9Y4E6 | |
| FVTGSHVGELIIWDA | 236 | Q9HAD4 | |
| AGIVVDGGSDWFVLT | 391 | Q9H1B5 | |
| WVVILDFFGIGSTAD | 1826 | Q5THJ4 | |
| VLAFTLIVLTGGFTW | 961 | Q5VV43 | |
| IIFASWDAEEFGLLG | 406 | Q9Y3Q0 |